Table 2 Medication
Medication | Baseline (n=17) | Pre-surgery (n=13) | Changes in medication from baseline to pre-surgery assessment | ||||
|---|---|---|---|---|---|---|---|
Started | Stopped | Dose reduced | Dose increased | Medication type changed | |||
Diabetes medication | Â | Â | Â | Â | Â | Â | Â |
 Insulin | 7 (41%) | 8 (62%) | 2 (15%) | 0 (0%) | 4 (31%) | 1 (8%) | 1 (8%) |
 Metformin | 13 (76%) | 10 (77%) | 0 (0%) | 0 (0%) | 1 (8%) | 0 (0%) | 0 (0%) |
 Sulfonylurea | 3 (18%) | 0 (0%) | 0 (0%) | 2 (15%) | 0 (0%) | 0 (0%) | 0 (0%) |
 SGLT2 Inhibitor | 3 (18%) | 7 (54%) | 4 (31%) | 0 (0%) | 0 (0%) | 0 (0%) | 1 (8%) |
 DPP4 inhibitor | 3 (18%) | 2 (15%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
 GLP-1 receptor agonist | 1 (6%) | 2 (15%) | 2 (15%) | 1 (8%) | 0 (0%) | 0 (0%) | 0 (0%) |
Other medication | Â | Â | Â | Â | Â | Â | Â |
 Statin | 14 (82%) | 12 (92%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 2 (15%) |
 ACE inhibitor | 7 (41%) | 3 (23%) | 0 (0%) | 2 (15%) | 0 (0%) | 0 (0%) | 0 (0%) |
 ARB | 4 (24%) | 1 (8%) | 0 (0%) | 3 (23%) | 0 (0%) | 0 (0%) | 0 (0%) |